VDAC

Cat.No. Product Name Information Product Use Citations Product Validations
S7242 Erastin Erastin is a ferroptosis activator by acting on mitochondrial VDAC, exhibiting selectivity for tumor cells bearing oncogenic RAS. Solutions are unstable and should be fresh-prepared.
Biochemical and Biophysical Research Communications, September 10, 2018, 1689-1695
PLoS One, May 12, 2016, e0154605
Oncology Letters, July 29, 2020, 57
Verified customer review of Erastin
S3544 VBIT-4 VBIT-4 is a voltage-dependent anion channel (VDAC) oligomerization inhibitor that decreases mitochondrial DNA (mtDNA) release, type I interferon (IFN) signaling, neutrophil extracellular traps, and disease severity in a mouse model of systemic lupus erythematosus.
Cell Rep, 2025, 44(5):115605
Cell Rep, 2025, 44(6):115834
Aging Cell, 2025, 24(9):e70135
S8936 VBIT-12 VBIT-12 is a potent inhibitor of Voltage-dependent anion-selective channel 1 (VDAC1), directly interacting with purified VDAC1, reducing its channel conductance and preventing VDAC1 oligomerization.
Journal of the American Heart Association, October 28, 2025, e045554T
Proceedings of the National Academy of Sciences, May 8, 2023, e2219644120
Environmental Pollution, February 15, 2022, 118720
E5770 DIDS sodium salt
Integrative Cancer Therapies, 2019, 1534735418822120
S0231 NSC15364 NSC 15364 (compound 59) is an inhibitor that directly interacts with VDAC1 and prevents VDAC1 oligomerization, concomitant with an inhibition of apoptosis.
Exp Cell Res, 2024, 434(2):113874